Pulseless electrical activity during caesarean delivery under spinal anaesthesia: a case report of severe anaphylactic reaction to Syntocinon

Pant, Deepanjali; Vohra, Vijay; Pandey, Saumya; Sood, Jayashree

doi:10.1016/j.ijoa.2008.09.004

Cited by 13 publications

(6 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…1,2,4-6,14-18 Other antibiotics, oxytocin, and agents used in perioperative settings, including neuromuscular blockers, epidural medications, general anesthetics, NRL, and chlorhexidine, have also been implicated. 1,3,7,[19][20][21][22][23][24][25][26] During labor, exercise rarely induces anaphylaxis. 27 Maternal anaphylaxis during breast-feeding is also rare; onset occurs in the first 3 days postpartum and is attributed to rapidly decreasing levels of progesterone.…”

Section: Etiologymentioning

confidence: 99%

Anaphylaxis during pregnancy

Simons

Schatz

2012

Journal of Allergy and Clinical Immunology

132

View full text Add to dashboard Cite

Section: Etiologymentioning

confidence: 99%

Anaphylaxis during pregnancy

Simons

Schatz

2012

Journal of Allergy and Clinical Immunology

132

View full text Add to dashboard Cite

“…Out of 100 fully evaluated, 52 references were included in the analysis as per selection criteria. [ 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 ] The flow diagram for the article selection is presented as Figure 1 .…”

Section: Resultsmentioning

confidence: 99%

“…The most common co-morbid condition was pregnancy (14.81%). [ 36 42 50 52 56 58 59 63 ] The drugs linked with anaphylaxis in pregnancy are iron sucrose (2), ranitidine (2), oxytocin (1), dinoprostone (1), cefotaxime (1) and diclofenac (1). Other co-morbid conditions were cardiovascular diseases (9.26%),[ 18 33 35 37 64 ] diabetes mellitus (3.70%),[ 37 64 ] chronic obstructive pulmonary disease (1.85%),[ 64 ] epilepsy (1.85%)[ 34 ] and cerebral malaria (1.85%).…”

Section: Resultsmentioning

confidence: 99%

Drug-induced anaphylactic reactions in Indian population: A systematic review

Patel¹,

Patel²,

Barvaliya³

et al. 2014

Indian Journal of Critical Care Medicine

View full text Add to dashboard Cite

Background:Epidemiological data on drug-induced anaphylactic reactions are limited in India and are largely depending on studies from developed countries.Aim:The aim was to analyze the published studies of drug-induced anaphylaxis reported from India in relation with causative drugs and other clinical characteristics.Materials and Methods:The electronic databases were searched for Indian publications from 1998 to 2013 describing anaphylactic reactions. The information was collected for demographics, set up in which anaphylaxis occurred, causative drugs, incubation period, clinical features, associated allergic conditions, past reactions, co-morbid conditions, skin testing, IgE assays, therapeutic intervention and mortality. Reactions were analyzed for severity, causality, and preventability. Data were extracted and summarized by absolute numbers, mean (95% confidence interval [CI]), percentages and odds ratio (OR) (95% CI).Results:From 3839 retrieved references, 52 references describing 54 reactions were included. The mean age was 35.31 (95% CI: 30.52–40.10) years. Total female patients were 61.11%. Majority reactions were developed in perioperative conditions (53.70%), ward (20.37%) and home (11.11%). The major incriminated groups were antimicrobials (18.52%), nonsteroidal antiinflammatory drugs-(NSAIDs) (12.96%) and neuromuscular blockers (12.96%). Common causative drugs were diclofenac (11.11%), atracurium (7.41%) and β-lactams (5.96%). Cardiovascular (98.15%) and respiratory (81.48%) symptoms dominated the presentation. Skin tests and IgE assays were performed in 37.03% and 18.52% cases, respectively. The fatal cases were associated with complications (OR =5.04; 95% CI: 1.41–17.92), cerebral hypoxic damage (OR =6.80; 95% CI: 2.14–21.58) and preventable reactions (OR =14.33; 95% CI: 2.33–87.97).Conclusion:Antimicrobials, NSAIDs, and neuromuscular blockers are common causative groups. The most fatal cases can be prevented by avoiding allergen drugs.

show abstract

“…Pant ve ark. [5] hipertansiyon, gestasyonel diyabet ve hipotroidisi olan ikiz gebe elektif sezaryeninde; bizimle benzer olarak spinal anestezi uygulamışlardır. Spinal blok sonrasında arteryel tansiyon ve nabız normal aralıklarda izlenmesine rağmen, oksitosin bolus uygulamasını takiben 1 dk.…”

Section: Discussionunclassified

“…Pant ve ark. [5] bizimle benzer olarak; anaflakside oksitosin ve koloidal mayiyi suçlamışlar, fakat anaflaksinin nedeni oksitosin olduğu saptanmıştır. Mertes ve ark.…”

Section: Discussionunclassified

Anaphylactic Shock in Caesarean Section

Şanlı¹,

Gülhaş²,

Erdil³

et al. 2014

GKDA Derg

View full text Add to dashboard Cite

Allerjen ile teması takiben, ürtikerden anaflaksiye kadar değişen alerjik reaksiyonlar görülebilir. Anafilaktik reaksiyonların sıklığı genel popülasyonda alerjik rinit ve astımı olanlarda daha yüksek oranda görülebilmektedir. Perianestezik anafilaksi önemlidir. Eğer erken tanıyıp tedavi edilmez ise potansiyel ciddi sonuçlara neden olabilir. Literatürde kolloid solüsyonlar, ranitidin, antibiyotikler ve lateks gibi sık kullanılan maddelere karşı anafilaksi bildirilmiştir. Oksitosin kullanımına bağlı anaflaktik şok gelişmesi ender bir yan etki olarak görülebilir. Biz, bu olgu ile allerji öyküsü olmayan gebede sezaryen ameliyatı sırasında oksitosin infüzyonundan hemen sonra gelişen anaflaktik şoktaki anestezi yönetimini sunmayı amaçladık.

show abstract

Pulseless electrical activity during caesarean delivery under spinal anaesthesia: a case report of severe anaphylactic reaction to Syntocinon

Cited by 13 publications

References 4 publications

Anaphylaxis during pregnancy

Anaphylaxis during pregnancy

Drug-induced anaphylactic reactions in Indian population: A systematic review

Anaphylactic Shock in Caesarean Section

Contact Info

Product

Resources

About